Aurora Cannabis
Price
Price
Frequently asked questions
What is Aurora Cannabis's market capitalization?
What is the Earnings Per Share (EPS) for Aurora Cannabis?
What are the analyst ratings and target price for Aurora Cannabis's stock?
What is Aurora Cannabis's revenue over the trailing twelve months?
What is the EBITDA for Aurora Cannabis?
What is the free cash flow of Aurora Cannabis?
What is the 5-year beta of Aurora Cannabis's stock?
How many employees does Aurora Cannabis have, and what sector and industry does it belong to?
What is the free float of Aurora Cannabis's shares?
Financials
Market Cap
$233.71M5Y beta
2.71EPS (TTM)
-$0.626Free Float
54.88MRevenue (TTM)
$212.15MEBITDA (TTM)
-$102.41MFree Cashflow (TTM)
-$43.63MPricing
Analyst Ratings
The price target is $5.541 and the stock is covered by 6 analysts.
Buy
1
Hold
5
Sell
0
Information
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
1,073
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker